marketbeat.com

Amundi Cuts Stake in Edwards Lifesciences Stock

Amundi logoAmundi
Sig1.15Sen-0.90Env0.00Soc0.00Gov0.00
Edwards Lifesciences logoEdwards Lifesciences
Sig0.88Sen+1.25Env0.00Soc0.00Gov0.00

An institutional investor reduced its Edwards Lifesciences stake, selling 90,461 shares and holding 2,579,748 shares. Rehmann Capital Advisory Group bought 130 shares and now owns 6,399 valued at about $546,000. Quadrant Capital added 0.9% and Aspen Investment Management gained 1.5%. A vice president sold shares totaling $56,966.57 and $49,536.64, leaving 40,034 shares. Citigroup lifted its price target to $110 and kept a buy rating.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro